Diagnosis and Treatment > Investigation > OCT

You are looking at 1 - 1 of 1 items

Mona Abouzaid Department of Diabetes and Endocrinology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK

Search for other papers by Mona Abouzaid in
Google Scholar
PubMed
Close
,
Ahmed Al-Sharefi Department of Diabetes and Endocrinology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK

Search for other papers by Ahmed Al-Sharefi in
Google Scholar
PubMed
Close
,
Satish Artham Department of Diabetes and Endocrinology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK
Department of Endocrinology and Diabetes, North Tees and Hartlepool Hospitals NHS Foundation Trust, Hartlepool, UK

Search for other papers by Satish Artham in
Google Scholar
PubMed
Close
,
Ibrahim Masri Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK

Search for other papers by Ibrahim Masri in
Google Scholar
PubMed
Close
,
Ajay Kotagiri Sunderland Eye Infirmary, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK

Search for other papers by Ajay Kotagiri in
Google Scholar
PubMed
Close
, and
Ashwin Joshi Department of Diabetes and Endocrinology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK

Search for other papers by Ashwin Joshi in
Google Scholar
PubMed
Close

Summary

An 82-year-old male with a proven diagnosis of primary hyperparathyroidism (PHPT) was found to have bilateral changes in the fundi during a routine eye examination which were consistent with SC. In this report, we discuss the link between SC and PHPT and question the need for prospective observational studies to establish the true association between these conditions. Though screening PHPT patients for SC might not be justified/warranted given the benign course of the latter, patients with SC need to be assessed for PHPT, as the former may be the first clue to an underlying treatable systemic disease.

Learning points:

  • Sclerochoroidal calcifications (SCs), though rare and harmless, could be associated with an underlying systemic disease, such as primary hyperparathyroidism (PHPT).

  • Biochemical screening for hypercalcaemia is a simple, cheap and widely available tool that could facilitate an identification of undiagnosed PHPT in patients with SC.

  • A joint care by endocrinologists and ophthalmologists is warranted for those patients, as thorough investigations and long-term follow-up plans are crucial.

Open access